The latest issue in the From Policy to Practice report series from The Gerontological Society of America (GSA) addresses recent labeling changes for OTC analgesics and highlights important considerations when recommending ...
Jul 17, 2018
0
3
Although this therapy is not curative, it nevertheless reduced the autistic disorders' severity in three-quarters of the children. The researchers have filed a request for authorisation to perform a multi-centre European ...
Dec 12, 2012
0
0
Regardless of the pain type, age and social class, women are more likely to be prescribed analgaesia than men. This is confirmed by a study conducted by several members of the Research Group on Public Health at the University ...
Oct 6, 2014
1
0
(HealthDay)—Opioid analgesics are involved in the majority of pharmaceutical-related overdose deaths, frequently involving drugs prescribed for mental health conditions, according to a research letter published in the Feb. ...
Feb 21, 2013
0
0
When evaluating the opioid crisis, research reveals that external factors—such as the volume of pre-filled syringes, or a default number of opioid tablets that could easily be ordered at discharge for the patient—can ...
May 7, 2021
0
2
A new study in CMAJ (Canadian Medical Association Journal) shows a small increased risk of congenital abnormalities in infants exposed to opioid medications in the first trimester of pregnancy.
Feb 7, 2022
0
19
A wide-reaching global review has found that some of the most common pain and fever medicines might increase vulnerability to infections like COVID-19, while others may hold hope for improving our immune response.
Mar 1, 2022
0
6
The combination of a high-dose NSAID with paracetamol does not increase the analgesic effect compared to paracetamol alone. Researchers also found that paracetamol alone is superior to high-dose NSAID alone for posttraumatic ...
Feb 9, 2021
0
0
(HealthDay)—The addition of methylprednisolone (MP) to opioid therapy does not appear to increase the analgesic effect for cancer pain, according to research published online July 7 in the Journal of Clinical Oncology.
Jul 16, 2014
0
0
(HealthDay)—Using subcutaneously administered ketamine in a dose-escalating regimen as an adjunct to opioids and standard co-analgesics does not have any clinical benefit in relieving cancer pain, but it is associated with ...
Sep 11, 2012
0
0
